{"drug_name": "Hemlibra", "description": "\nEMICIZUMAB (em i SIZ ue mab) prevents or reduces how often bleeding episodes occur in people with hemophilia A. It works by helping your body make factor VIII, a protein that helps your blood clot. This lowers the risk of bleeding. It is a monoclonal antibody.\nThis medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.\nCOMMON BRAND NAME(S): Hemlibra\n", "side_effects": "\nSide effects that you should report to your care team as soon as possible:\nAllergic reactions\u2014skin rash, itching, hives, swelling of the face, lips, tongue, or throat\nBlood clot\u2014pain, swelling, or warmth in the leg, shortness of breath, chest pain\nSide effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):\nHeadache\nJoint pain\nPain, redness, or irritation at injection site\nThis list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.\n", "monitoring": "\nVisit your care team for regular checks on your progress. Tell your care team if your symptoms do not start to get better or if they get worse. You may need blood work done while you are taking this medication.\n"}